ACE (angiotensin converting enzyme) inhibitors -- such as Capoten ... Another study compared the drug Diovan, an ARB, with Coreg, a beta-blocker. The study compared the effects of the two drugs ...

The Heart Failure Drugs Market is poised for a transformative decade between 2025 and 2035. As heart failure continues to pose a major global health challenge, the demand for effective therapeutic ...

This study describes coformulations with short-acting beta-blockers or nitrates, matched to DMT’s pharmacokinetics, to mitigate peripheral cardiovascular risks without compromising central therapeutic ...

Before receiving a kidney transplant, patients with autosomal dominant polycystic kidney disease often undergo a nephrectomy. But there hasn’t been clear guidance on who’s a good candidate ...

Oral beta-blockers, ACE inhibitors (ACE-Is), angiotensin receptor blockers (ARBs) and calcium channel blockers (CCBs) are most commonly used for chronic hypertension. In this review, we discussed ...

15,16 A particular issue has been the need for direct comparisons, including formally conducted tests for “noninferiority,” with the implications this has for patient selection, choice of ACE ...

Beta-blockers can treat a variety of conditions including diabetes. They might cause certain side effects such as headaches and fatigue. People with diabetes tend to develop heart disease or ...

ACE inhibitors are well-established for limiting morbidity and mortality after MI, particularly in patients with LV dysfunction, heart failure, or both. To test the hypothesis that an angiotensin ...

The trials also demonstrated that beta-blockers were the first treatment for chronic heart failure which reduced sudden cardiac death angiotensin converting enzyme (ACE) inhibitors had reduced ...

Consistently, glomerular functional and structural changes are blunted by treatment with complement inhibitors, and vascular changes ... trandolapril and the non-dihydropyridine calcium-channel ...